Prospect of acromegaly therapy: molecular mechanism of clinical drugs octreotide and paltusotine.

MLA

Zhao, Jie, et al. “Prospect of Acromegaly Therapy: Molecular Mechanism of Clinical Drugs Octreotide and Paltusotine.” Nature Communications, vol. 14, no. 1, Feb. 2023, p. 962. EBSCOhost, https://doi.org/10.1038/s41467-023-36673-z.

APA

Zhao, J., Fu, H., Yu, J., Hong, W., Tian, X., Qi, J., Sun, S., Zhao, C., Wu, C., Xu, Z., Cheng, L., Chai, R., Yan, W., Wei, X., & Shao, Z. (2023). Prospect of acromegaly therapy: molecular mechanism of clinical drugs octreotide and paltusotine. Nature Communications, 14(1), 962. https://doi.org/10.1038/s41467-023-36673-z

Chicago

Zhao, Jie, Hong Fu, Jingjing Yu, Weiqi Hong, Xiaowen Tian, Jieyu Qi, Suyue Sun, et al. 2023. “Prospect of Acromegaly Therapy: Molecular Mechanism of Clinical Drugs Octreotide and Paltusotine.” Nature Communications 14 (1): 962. doi:10.1038/s41467-023-36673-z.